| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/03/2005 | EP1558224A1 Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously |
| 08/03/2005 | EP1558219A1 Pharmaceutical formulation of olanzapine |
| 08/03/2005 | EP1558215A1 Sterile gelling agents |
| 08/03/2005 | EP1558214A1 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same |
| 08/03/2005 | EP1558213A2 Mucoadhesive tetracycline formulations |
| 08/03/2005 | EP1558210A2 Cartilage enhancing food supplements with sucralose and methods of preparing the same |
| 08/03/2005 | EP1558206A1 Formulations for topical delivery of bioactive substances and methods for their use |
| 08/03/2005 | EP1507860A4 Dynamic action reference tools |
| 08/03/2005 | EP1482979A4 Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract |
| 08/03/2005 | EP1359976A4 Fluid retention assembly for an iontophoretic delivery |
| 08/03/2005 | EP1207861B1 Treatment of fungal infections utilizing a fungal growth medium |
| 08/03/2005 | EP1141111B1 Gel compositions |
| 08/03/2005 | EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof |
| 08/03/2005 | EP0988108B1 superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties |
| 08/03/2005 | EP0906243B1 Dissolvable oxides for biological applications |
| 08/03/2005 | EP0851925B1 Human growth hormone variants |
| 08/03/2005 | EP0707596B1 Polymer-peptide conjugates |
| 08/03/2005 | EP0702722B1 Plasmids suitable for gene therapy |
| 08/03/2005 | EP0639070B1 Use of borate-polyol complexes in ophthalmic compositions |
| 08/03/2005 | CN1650024A Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 08/03/2005 | CN1649977A Refrigerant composition, refrigerant auxiliary compositions and uses thereof |
| 08/03/2005 | CN1649932A Polymeric microemulsions |
| 08/03/2005 | CN1649901A Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 08/03/2005 | CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/03/2005 | CN1649625A Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 08/03/2005 | CN1649621A Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2005 | CN1649614A Active agent delivery systems and methods for protecting and administering active agents |
| 08/03/2005 | CN1649603A Aqueous compositions containing metronidazole |
| 08/03/2005 | CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 08/03/2005 | CN1649592A Pharmaceutical composition |
| 08/03/2005 | CN1649588A New pharmaceutical compositions based on anticholinergics and PED-IV inhibitors |
| 08/03/2005 | CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues |
| 08/03/2005 | CN1649572A Non-gelatin capsule shell formulation comprising iota-carrageenan and kappa-carrageenan |
| 08/03/2005 | CN1649569A Controlled release dosage forms |
| 08/03/2005 | CN1649568A Pharmaceutical compositions for the treatment of asthma |
| 08/03/2005 | CN1649567A Composition having gelling properties for the prolonged delivery of bioactive substances |
| 08/03/2005 | CN1649551A Drug-delivery endovascular stent and method for treating restenosis |
| 08/03/2005 | CN1649517A Soft drink replacer |
| 08/03/2005 | CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 08/03/2005 | CN1649504A Sugar-free hard coatings prepared from liquid maltitol comprising DP4+ fraction |
| 08/03/2005 | CN1648141A Temperature sensitive linear polymer containing siloxane side chain and its water gel and preparing method |
| 08/03/2005 | CN1647806A Leadless plaster medium for Chinese medicine and preparing method |
| 08/03/2005 | CN1647797A Formula of submicro emulsion of norcantharidine injection and preparing process |
| 08/03/2005 | CN1213087C Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizers |
| 08/03/2005 | CN1213059C Rapid dehydration of proteins |
| 08/03/2005 | CN1213058C FAP-activated anti-tumor compounds |
| 08/03/2005 | CN1212866C Biodegradable polymer scaffold structure |
| 08/03/2005 | CN1212848C L-histidine in ophthalmic solutions |
| 08/03/2005 | CN1212847C Improved ophthalmic and contact lens solutions containing forms of vitamin B |
| 08/03/2005 | CN1212838C Controlled-release dosage forms comprising zolpidem or salt thereof |
| 08/03/2005 | CN1212834C Fluoxetine enteric soluble micro-capsule |
| 08/03/2005 | CN1212833C Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 08/03/2005 | CN1212832C Soft capsule containing vinyl ester and poly ether polymer, its use and producing method |
| 08/03/2005 | CN1212831C Pharmaceutical preparations |
| 08/03/2005 | CN1212830C Delivery of solid drug compositions |
| 08/02/2005 | US6924360 Antitumor agents |
| 08/02/2005 | US6924268 Method for inactivating gonadotrophs |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924264 chain extension of polypeptides using polymers selected from polyethylene glycol, polylactams, albumin, gelatin, acrylic polymers, fatty acids, polysaccharides, lipid and/or dextrans; antidiabetic agents |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | US6923986 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 08/02/2005 | US6923984 Cushioning wax beads for making solid shaped articles |
| 08/02/2005 | US6923983 Transdermal delivery of hormones |
| 08/02/2005 | US6923981 Fast dissolving orally consumable films |
| 08/02/2005 | US6923976 Methods compositions and devices utilizing stinging cells/capsules for delivering therapeutic or a cosmetic agent into a tissue |
| 08/02/2005 | US6923956 Liquid interferon-β formulations |
| 08/02/2005 | US6923654 Manikin and eye device apparatus, methods and articles of manufacture |
| 08/02/2005 | CA2360647C Fast dispersing dosage forms free of gelatin |
| 08/02/2005 | CA2275033C Biodegradable targetable microparticle delivery system |
| 08/02/2005 | CA2267904C Fusogenic liposome composition and method |
| 08/02/2005 | CA2264094C Structured water for enhanced moisturization |
| 08/02/2005 | CA2190837C Transdermal delivery of anti-epileptic drugs |
| 08/02/2005 | CA2169297C Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 08/02/2005 | CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 07/30/2005 | CA2495048A1 Hemostatic compositions and devices |
| 07/30/2005 | CA2494431A1 Pharmaceutical hard capsule containing inorganic substance |
| 07/28/2005 | WO2005068639A2 Particle-induced ghrelin immune response |
| 07/28/2005 | WO2005068498A2 Human therapeutic cells secreting nerve growth factor |
| 07/28/2005 | WO2005068490A1 Inclusion complexes of perindopril |
| 07/28/2005 | WO2005068483A1 Metal complexes having vitamin b12 as a ligand |
| 07/28/2005 | WO2005067994A1 Crosslinked hyaluronic acid compositions for tissue augmentation |
| 07/28/2005 | WO2005067980A2 Design of therapeutics and therapeutics |
| 07/28/2005 | WO2005067979A1 Ahybrid of itraconazole with a layered silicate |
| 07/28/2005 | WO2005067978A2 Thiopeptide conjugates for drug delivery |
| 07/28/2005 | WO2005067977A1 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof |
| 07/28/2005 | WO2005067976A2 Direct compression formulation and process |
| 07/28/2005 | WO2005067975A1 Title: a sustained release captopril formulation having a supermolecular intercalation structure and the preparation process thereof |
| 07/28/2005 | WO2005067963A1 Use of polyethylene glycol-modified interferon-alpha in therapeutic dosing regimens |
| 07/28/2005 | WO2005067959A1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| 07/28/2005 | WO2005067942A1 Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| 07/28/2005 | WO2005067941A1 Topical aciclovir formulation |
| 07/28/2005 | WO2005067939A1 Therapeutically useful antibacterial compounds |
| 07/28/2005 | WO2005067918A1 Active oxygen eliminator originating in natural material and use of the same |
| 07/28/2005 | WO2005067897A1 Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid |
| 07/28/2005 | WO2005067893A2 Pharmaceutical compositions comprising midazolam in a high concentration |
| 07/28/2005 | WO2005067891A1 Compositions comprosing memantine and polyanionic polymers for administration to the eye |
| 07/28/2005 | WO2005067890A2 Controlled release cgrp delivery composition for cardiovascular and renal indications |
| 07/28/2005 | WO2005067517A2 Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers |
| 07/28/2005 | WO2005054446A3 Use of polysulphated alginate in cellular matrices |
| 07/28/2005 | WO2005051428A3 Method for obtaining a thermoreversible gel with a controlled three-dimensional structure, and gel obtained |